145 related articles for article (PubMed ID: 2407754)
1. The relationship of alprazolam dose to steady-state plasma concentrations.
Ciraulo DA; Antal EJ; Smith RB; Olson DR; Goldberg DA; Rand EH; Raskin RB; Phillips JP; Shader RI; Greenblatt DJ
J Clin Psychopharmacol; 1990 Feb; 10(1):27-32. PubMed ID: 2407754
[TBL] [Abstract][Full Text] [Related]
2. Response of panic disorder to fixed doses of alprazolam or imipramine.
Uhlenhuth EH; Matuzas W; Glass RM; Easton C
J Affect Disord; 1989; 17(3):261-70. PubMed ID: 2529295
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and clinical effects of alprazolam following single and multiple oral doses in patients with panic disorder.
Ciraulo DA; Barnhill JG; Boxenbaum HG; Greenblatt DJ; Smith RB
J Clin Pharmacol; 1986 Apr; 26(4):292-8. PubMed ID: 2871050
[TBL] [Abstract][Full Text] [Related]
4. Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam.
Swinson RP; Pecknold JC; Kuch K
Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):105-13. PubMed ID: 3628823
[TBL] [Abstract][Full Text] [Related]
5. Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam.
Charney DS; Woods SW
J Clin Psychiatry; 1989 Nov; 50(11):418-23. PubMed ID: 2808308
[TBL] [Abstract][Full Text] [Related]
6. Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia.
Lesser IM; Lydiard RB; Antal E; Rubin RT; Ballenger JC; DuPont R
Am J Psychiatry; 1992 Nov; 149(11):1556-62. PubMed ID: 1415824
[TBL] [Abstract][Full Text] [Related]
7. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
Pyke RE; Greenberg HS
J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
[TBL] [Abstract][Full Text] [Related]
8. Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment.
Sheehan DV; Coleman JH; Greenblatt DJ; Jones KJ; Levine PH; Orsulak PJ; Peterson M; Schildkraut JJ; Uzogara E; Watkins D
J Clin Psychopharmacol; 1984 Apr; 4(2):66-75. PubMed ID: 6142907
[TBL] [Abstract][Full Text] [Related]
9. Plasma alprazolam concentrations. Relation to efficacy and side effects in the treatment of panic disorder.
Greenblatt DJ; Harmatz JS; Shader RI
Arch Gen Psychiatry; 1993 Sep; 50(9):715-22. PubMed ID: 8357297
[TBL] [Abstract][Full Text] [Related]
10. Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks.
Munjack DJ; Crocker B; Cabe D; Brown R; Usigli R; Zulueta A; McManus M; McDowell D; Palmer R; Leonard M
J Clin Psychopharmacol; 1989 Feb; 9(1):22-7. PubMed ID: 2651490
[TBL] [Abstract][Full Text] [Related]
11. Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
Lesser IM; Rubin RT; Pecknold JC; Rifkin A; Swinson RP; Lydiard RB; Burrows GD; Noyes R; DuPont RL
Arch Gen Psychiatry; 1988 May; 45(5):437-43. PubMed ID: 3282480
[TBL] [Abstract][Full Text] [Related]
12. Alprazolam in the treatment of panic disorders.
Liebowitz MR; Fyer AJ; Gorman JM; Campeas R; Levin A; Davies SR; Goetz D; Klein DF
J Clin Psychopharmacol; 1986 Feb; 6(1):13-20. PubMed ID: 2869059
[TBL] [Abstract][Full Text] [Related]
13. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
Noyes R; DuPont RL; Pecknold JC; Rifkin A; Rubin RT; Swinson RP; Ballenger JC; Burrows GD
Arch Gen Psychiatry; 1988 May; 45(5):423-8. PubMed ID: 3358644
[TBL] [Abstract][Full Text] [Related]
14. A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder.
Lydiard RB; Lesser IM; Ballenger JC; Rubin RT; Laraia M; DuPont R
J Clin Psychopharmacol; 1992 Apr; 12(2):96-103. PubMed ID: 1573046
[TBL] [Abstract][Full Text] [Related]
15. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
Pecknold JC; Swinson RP; Kuch K; Lewis CP
Arch Gen Psychiatry; 1988 May; 45(5):429-36. PubMed ID: 3282479
[TBL] [Abstract][Full Text] [Related]
16. Lorazepam vs. alprazolam in the treatment of panic disorder.
Schweizer E; Pohl R; Balon R; Fox I; Rickels K; Yeragani VK
Pharmacopsychiatry; 1990 Mar; 23(2):90-3. PubMed ID: 2187213
[TBL] [Abstract][Full Text] [Related]
17. Alprazolam levels and response in panic disorder: preliminary results.
Wincor MZ; Munjack DJ; Palmer R
J Clin Psychopharmacol; 1991 Feb; 11(1):48-51. PubMed ID: 2040715
[TBL] [Abstract][Full Text] [Related]
18. Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
Schweizer E; Rickels K; Weiss S; Zavodnick S
Arch Gen Psychiatry; 1993 Jan; 50(1):51-60. PubMed ID: 8422222
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of alprazolam and imipramine on cerebrospinal fluid monoamine metabolites and neuropeptides in panic disorder.
Lepola U; Jolkkonen J; Rimón R; Riekkinen P
Neuropsychobiology; 1989; 21(4):182-6. PubMed ID: 2483580
[TBL] [Abstract][Full Text] [Related]
20. Panic attacks and agoraphobia: low dose clomipramine treatment.
Gloger S; Grunhaus L; Gladic D; O'Ryan F; Cohen L; Codner S
J Clin Psychopharmacol; 1989 Feb; 9(1):28-32. PubMed ID: 2651491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
